Viridian Therapeutics, Inc./DE
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $16.5M | $183.2M | $30.9M |
| Jun 2022 | $27.9M | $169.8M | $31.3M |
| Sep 2022 | $31.6M | $440.6M | $344.2M |
| Dec 2022 | $40.0M | $435.1M | $155.6M |
| Mar 2023 | $36.1M | $386.6M | $88.5M |
| Jun 2023 | $35.6M | $351.5M | $87.1M |
| Sep 2023 | $45.2M | $328.8M | $111.6M |
| Dec 2023 | $48.4M | $490.4M | $102.8M |
| Mar 2024 | $47.9M | $630.4M | $91.6M |
| Jun 2024 | $56.3M | $585.7M | $107.7M |
| Sep 2024 | $64.4M | $771.9M | $200.3M |
| Dec 2024 | $70.8M | $742.4M | $99.6M |
| Mar 2025 | $56.5M | $661.0M | $116.2M |
| Jun 2025 | $67.2M | $582.3M | $117.3M |
| Sep 2025 | $74.2M | $577.1M | $169.6M |
| Dec 2025 | $177.3M | $899.4M | $212.4M |
| Mar 2026 | $153.0M | $789.0M | $176.3M |
| Jun 2026 | $435.1M | $1.10B | $165.0M |